Key result
An intravascular wireless and batteryless microscale stimulator achieved a >5 V stimulation threshold with up to 20 mm displacement and 20° misalignment in bovine tissue and FEM simulations.
Why the study?
Achieving efficient wireless power transfer and effective operational range within anatomical constraints has remained a challenge for batteryless implantable biomedical devices.
A novel intravascular wireless and batteryless microscale stimulator demonstrated technical feasibility and sufficient power transfer in preclinical models, suggesting potential for minimally invasive pacing.
Answers are grounded in this paper and cite their sources.
Early human data support feasibility of batteryless intravascular stimulation; leaves open clinical translation pending larger safety and efficacy trials.
The elimination of integrated batteries in biomedical implants holds great promise for improving health outcomes in patients with implantable devices. However, despite extensive research in wireless power transfer, achieving efficient power transfer and effective operational range have remained a hindering challenge within anatomical constraints. OBJECTIVE: We hereby demonstrate an intravascular wireless and batteryless microscale stimulator, designed for (1) low power dissipation via intermittent transmission and (2) reduced fixation mechanical burden via deployment to the anterior cardiac vein (ACV, ∼3.8 mm in diameter). METHODS: We introduced a unique coil design circumferentially confined to a 3 mm diameter hollow-cylinder that was driven by a novel transmitter-based control architecture with improved power efficiency. RESULTS: We examined wireless capacity using heterogenous bovine tissue, demonstrating >5 V stimulation threshold with up to 20 mm transmitter-receiver displacement and 20° of misalignment. Feasibility for human use was validated using Finite Element Method (FEM) simulation of the cardiac cycle, guided by pacer phantom-integrated Magnetic Resonance Images (MRI). CONCLUSION: This system design thus enabled sufficient wireless power transfer in the face of extensive stimulator miniaturization. SIGNIFICANCE: Our successful feasibility studies demonstrated the capacity for minimally invasive deployment and low-risk fixation.
No takes yet. Share an insight, caveat, or question.
Abiri et al. (2020) studied Implantable device candidates. Intravascular wireless and batteryless microscale stimulator was evaluated on Wireless capacity (stimulation threshold, displacement, and misalignment). An intravascular wireless and batteryless microscale stimulator achieved a >5 V stimulation threshold with up to 20 mm displacement and 20° misalignment in bovine tissue and FEM simulations.
Synapse has enriched 10 related papers. Consider them for comparative context: